• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性中心性浆液性脉络膜视网膜病变患者发生冠心病的风险增加:一项基于人群的队列研究结果。

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

机构信息

Department of Ophthalmology, Changhua Christian Hospital, , Changhua, Taiwan.

出版信息

Br J Ophthalmol. 2014 Jan;98(1):110-4. doi: 10.1136/bjophthalmol-2013-303945. Epub 2013 Oct 29.

DOI:10.1136/bjophthalmol-2013-303945
PMID:24169652
Abstract

AIMS

To investigate whether patients with central serous chorioretinopathy (CSCR) have increased risk of coronary heart disease (CHD).

METHODS

Population-based retrospective cohort and case control study. Longitudinal data from the Taiwan National Health Insurance Research Database (2000-2009) were analysed. The study cohort comprised 835 patients with a diagnosis of CSCR and 4175 age and gender matched patients without CSCR. Kaplan-Meier plots and log-rank tests were used to compare differences in the hazard rates of CHD between the CSCR and non-CSCR cohorts. Stratified Cox proportional hazard models were applied to examine the association between CSCR and CHD, adjusting for potential confounding factors.

RESULTS

The 5-year CHD cumulative incidence for patients with CSCR was nearly twofold that of the non-CSCR cohort (6.12% vs 3.29%, p=0.004) from the log-rank test. The adjusted CHD HR of CSCR versus non-CSCR was 1.61 (95% CI 1.12 to 2.30, p=0.009) from the Cox model. Specifically, the HR for male patients was 1.72 (95% CI 1.14 to 2.59, p=0.010) and for female patients it was 1.34 (95% CI 0.64 to 2.84, p=0.438).

CONCLUSIONS

Male patients with CSCR had a significantly higher CHD rate than those without CSCR, indicating that CSCR may be a potential risk factor for the development of CHD for men.

摘要

目的

探讨中心性浆液性脉络膜视网膜病变(CSCR)患者发生冠心病(CHD)的风险是否增加。

方法

这是一项基于人群的回顾性队列和病例对照研究。对来自台湾全民健康保险研究数据库(2000-2009 年)的纵向数据进行分析。研究队列包括 835 例 CSCR 患者和 4175 例年龄和性别相匹配的非 CSCR 患者。采用 Kaplan-Meier 图和对数秩检验比较 CSCR 组和非 CSCR 组 CHD 危险率的差异。应用分层 Cox 比例风险模型,调整潜在混杂因素,检验 CSCR 与 CHD 之间的关联。

结果

CSCR 患者的 5 年 CHD 累积发病率几乎是非 CSCR 队列的两倍(6.12%对 3.29%,p=0.004,对数秩检验)。Cox 模型调整后的 CSCR 与非 CSCR 相比 CHD 的 HR 为 1.61(95%CI 1.12 至 2.30,p=0.009)。具体而言,男性患者的 HR 为 1.72(95%CI 1.14 至 2.59,p=0.007),女性患者为 1.34(95%CI 0.64 至 2.84,p=0.438)。

结论

CSCR 男性患者的 CHD 发生率明显高于非 CSCR 患者,表明 CSCR 可能是男性发生 CHD 的潜在危险因素。

相似文献

1
Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.男性中心性浆液性脉络膜视网膜病变患者发生冠心病的风险增加:一项基于人群的队列研究结果。
Br J Ophthalmol. 2014 Jan;98(1):110-4. doi: 10.1136/bjophthalmol-2013-303945. Epub 2013 Oct 29.
2
Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.男性中心性浆液性脉络膜视网膜病变患者勃起功能障碍风险增加——一项回顾性队列研究。
Acta Ophthalmol. 2013 Nov;91(7):666-71. doi: 10.1111/j.1755-3768.2012.02528.x. Epub 2012 Sep 23.
3
Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.中心性浆液性脉络膜视网膜病变与缺血性脑卒中风险:基于人群的队列研究。
Br J Ophthalmol. 2012 Dec;96(12):1484-8. doi: 10.1136/bjophthalmol-2012-301810. Epub 2012 Sep 13.
4
Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.成人使用口服皮质类固醇后发生中心性浆液性脉络膜视网膜病变的风险:一项基于台湾人群的研究。
Retina. 2014 Sep;34(9):1867-74. doi: 10.1097/IAE.0000000000000159.
5
Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.局部用眼科皮质类固醇与中心性浆液性脉络膜视网膜病变之间的关联:一项基于台湾人群的研究。
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4083-9. doi: 10.1167/iovs.14-16360.
6
Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study.评估中心性浆液性脉络膜视网膜病变与肝硬化的关系:一项全国性、基于人群的研究。
J Chin Med Assoc. 2021 Jun 1;84(6):655-663. doi: 10.1097/JCMA.0000000000000533.
7
RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY.中心性浆液性脉络膜视网膜病变伴视网膜静脉阻塞的风险
Retina. 2016 Apr;36(4):798-804. doi: 10.1097/IAE.0000000000000796.
8
RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY.中心性浆液性脉络膜视网膜病变伴发孔源性视网膜脱离的风险
Retina. 2016 Aug;36(8):1446-53. doi: 10.1097/IAE.0000000000000946.
9
Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.中心性浆液性脉络膜视网膜病变男性患者冠心病风险增加:一项基于人群的队列研究结果
Br J Ophthalmol. 2014 Jul;98(7):997. doi: 10.1136/bjophthalmol-2014-305148. Epub 2014 Mar 19.
10
Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.肾病综合征患者发生中心性浆液性脉络膜视网膜病变的风险增加:一项基于人群的队列研究。
J Chin Med Assoc. 2021 Nov 1;84(11):1060-1069. doi: 10.1097/JCMA.0000000000000591.

引用本文的文献

1
Increased oxidative stress biomarkers in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中氧化应激生物标志物增加。
Sci Rep. 2024 Sep 10;14(1):21099. doi: 10.1038/s41598-024-71890-6.
2
Evaluation of carotid intima-media thickness measurements in patients with central serous chorioretinopathy.评估中心性浆液性脉络膜视网膜病变患者的颈动脉内膜中层厚度测量值。
Radiologie (Heidelb). 2024 Nov;64(Suppl 1):153-159. doi: 10.1007/s00117-024-01358-1. Epub 2024 Sep 6.
3
Understanding the relationship between pachychoroid spectrum disorders and retinitis pigmentosa: A review of the evidence.
了解厚脉络膜谱系疾病与色素性视网膜炎的关系:对证据的综述。
Indian J Ophthalmol. 2024 Jul 1;72(7):956-961. doi: 10.4103/IJO.IJO_2909_23. Epub 2024 Apr 16.
4
Central Serous Chorioretinopathy Risk Factors in An Iranian Cohort: A Case-control Study.伊朗队列中中心性浆液性脉络膜视网膜病变的危险因素:一项病例对照研究。
J Ophthalmic Vis Res. 2023 Nov 30;18(4):410-416. doi: 10.18502/jovr.v18i4.14553. eCollection 2023 Oct-Dec.
5
Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.中心性浆液性脉络膜视网膜病变:病理生理学、全身关联及一种新的病因分类
Taiwan J Ophthalmol. 2022 Dec 5;12(4):381-393. doi: 10.4103/2211-5056.362601. eCollection 2022 Oct-Dec.
6
Retinal and choroidal vasoreactivity in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的视网膜和脉络膜血管反应性。
Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3825-3836. doi: 10.1007/s00417-022-05757-9. Epub 2022 Jul 15.
7
Intima-Media Thickness Measurements of the Common Carotid Artery in Patients with Central Serous Chorioretinopathy: A Case-Control Study.中心性浆液性脉络膜视网膜病变患者颈总动脉内膜中层厚度测量:一项病例对照研究。
J Ophthalmol. 2021 Sep 4;2021:6652373. doi: 10.1155/2021/6652373. eCollection 2021.
8
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization.OCT-angiography 检测脉络膜新生血管的中渗经半剂量维替泊芬光动力疗法 3 年随访
Sci Rep. 2021 Jun 24;11(1):13286. doi: 10.1038/s41598-021-92693-z.
9
Response to comments on: Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy.对关于“急性中心性浆液性脉络膜视网膜病变患者单核细胞与高密度脂蛋白及中性粒细胞与淋巴细胞比值”评论的回复
Indian J Ophthalmol. 2021 Feb;69(2):472. doi: 10.4103/ijo.IJO_3383_20.
10
Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings.中心性浆液性脉络膜视网膜病变患者的甲襞视频毛细血管显微镜检查及其与形态学和功能检查结果的关系
J Clin Med. 2020 Nov 30;9(12):3891. doi: 10.3390/jcm9123891.